Body weight gain induced by atypical antipsychotics: An extension of the monocygotic twin and sib pair study

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 2, 2010, Pages 207-211

  Gebhardt, S ^a   Theisen, F M ^a,b   Haberhausen, M ^a   Heinzel Gutenbrunner, M ^a   Wehmeier, P M ^a   Krieg, J C ^a   Kuhnau W ^c   Schmidtke, J ^c   Remschmidt, H ^a   Hebebrand, J ^d  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Herz Jesu Krankenhaus Fulda   (Germany)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Atypical antipsychotics; Body mass index; Body weight; Clozapine; Genetics; Olanzapine; Risperdone; Set point; Twin study; Weight regulation

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HERITABILITY; HUMAN; MALE; MEDICAL RECORD; MONOZYGOTIC TWINS; RETROSPECTIVE STUDY; SCREENING TEST; SIBLING; SIDE EFFECT; TELEPHONE; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY MASS INDEX; BODY WEIGHT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISPERIDONE; SIBLINGS; TWINS, MONOZYGOTIC; WEIGHT GAIN; YOUNG ADULT;

EID: 77749258320     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01084.x     Document Type: Article

References (26)

1. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry, 156, 1686 1696.
2. Simpson MM, Goetz RR, Devlin MJ, Goetz SA, Walsh BT (2001) Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods. Journal of Clinical Psychiatry, 62, 694 700.
3. Fleischhaker C, Heiser P, Hennighausen K et al. (2007) Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents. Journal of Neural Transmission, 114, 273 280.
4. Meltzer HY, Bobo WV, Roy A et al. (2008) A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. Journal of Clinical Psychiatry, 69, 274 285.
5. Saddichha S, Ameen S, Akhtar S (2008) Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. Journal of Clinical Psychopharmacology, 28, 27 31.
6. Müller DJ, Muglia P, Fortune T, Kennedy JL (2004) Pharmacogenetics of antipsychotic-induced weight gain. Pharmacological Research, 49, 309 329.
7. Correll CU, Malhotra AK (2004) Pharmacogenetics of antipsychotic-induced weight gain. Psychopharmacology, 174, 477 489.
8. Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL (2001) Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. Journal of Clinical Psychiatry, 62 (Suppl. 23 45 66.
9. Basile VS, Masellis M, De Luca V, Meltzer HY, Kennedy JL (2002) -759C/T genetic variation of 5HT2C receptor and clozapine-induced weight gain. Lancet, 360, 1790 1791.
10. Hong CJ, Lin CH, Yu YW, Yang KH, Tsai SJ (2001) Genetic variants of the serotonin system and weight change during clozapine treatment. Pharmacogenetics, 11, 265 268.
11. Hong CJ, Lin CH, Yu YW, Chang SC, Wang SY, Tsai SJ (2002) Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment. Psychiatric Genetics, 12, 169 171.
12. Reynolds GP, Zhang ZJ, Zhang XB (2002) Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet, 359, 2086 2087.
13. Reynolds GP, Zhang Z, Zhang X (2003) Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. American Journal of Psychiatry, 160, 677 679.
14. Tsai SJ, Hong CJ, Yu YW, Lin CH (2002) -759C/T genetic variation of 5HT2C receptor and clozapine-induced weight gain. Lancet, 360, 1790.
15. Tsai SJ, Yu YW, Lin CH, Wang YC, Chen JY, Hong CJ (2004) Association study of adrenergic beta3 receptor (Trp64Arg) and G-protein beta3 subunit gene (C825T) polymorphisms and weight change during clozapine treatment. Neuropsychobiology, 50, 37 40.
16. Theisen FM, Hinney A, Brömel T et al. (2004) Lack of association between -759C/T polymorphism of 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals. Psychiatric Genetics, 14, 139 142.
17. Ellingrod VL, Bishop JR, Moline J, Lin YC, Miller del D (2007) Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. Psychopharmacology Bulletin, 40, 57 62.
18. Hill MJ, Reynolds GP (2007) 5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity. Brain Research, 1149, 14 17.
19. Zhang XY, Tan YL, Zhou DF et al. (2007) Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population. Journal of Clinical Psychopharmacology, 27, 246 251.
20. Chagnon YC, Merette C, Lamarche J, Bouchard RH, Roy MA, Maziade M (2005). Possible association of the pro-melanin concentrating hormone (PMCH) gene with the body mass index (BMI) as a side effect of antipsychotics. New York : 4th Annual Meeting, Pharmacogenetics in Psychiatry.
21. Ellingrod VL, Miller D, Schultz SK, Wehring H, Arndt S (2002) CYP2D6 polymorphisms and atypical antipsychotic weight gain. Psychiatric Genetics, 12, 55 58.
22. Wang YC, Bai YM, Chen JY, Lin CC, Lai IC, Liou YJ (2005) C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population. Pharmacogenetics and Genomics, 15, 743 748.
23. Le Hellard S, Theisen FM, Haberhausen M et al. (2009). Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Mol Psychiatry, 14, 308 317.
24. Chagnon YC (2006) Susceptibility genes for the side effect of antipsychotics on body weight and obesity. Current Drug Targets, 7, 1681 1695.
25. Theisen FM, Gebhardt S, Haberhausen M et al. (2005) Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs. Psychiatric Genetics, 15, 285 289.
26. Vogel F, Motulsky AG (1997). Human genetics. Problems and approaches. 3rd edn. Berlin : Springer-Verlag.